These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 3760368

  • 1. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
    Steinbeck G, Bach P, Haberl R.
    J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts.
    Kuchar DL, Garan H, Venditti FJ, Finkelstein D, Rottman JN, McComb J, McGovern BA, Ruskin JN.
    Am J Cardiol; 1989 Jul 01; 64(1):33-6. PubMed ID: 2741811
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Antiarrhythmia effectiveness of oral sotalol in patients with coronary heart disease and ventricular tachycardias].
    Trappe HJ, Klein H, Lichtlen PR.
    Z Kardiol; 1987 Oct 01; 76(10):630-4. PubMed ID: 3687165
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of sotalol guided by programmed electrical stimulation for sustained ventricular arrhythmias secondary to coronary artery disease.
    Young GD, Kerr CR, Mohama R, Boone J, Yeung-Lai-Wah JA.
    Am J Cardiol; 1994 Apr 01; 73(9):677-82. PubMed ID: 8166065
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
    Nademanee K, Feld G, Hendrickson J, Singh PN, Singh BN.
    Circulation; 1985 Sep 01; 72(3):555-64. PubMed ID: 4017207
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
    Kühlkamp V, Mermi J, Mewis C, Seipel L.
    J Cardiovasc Pharmacol; 1997 Mar 01; 29(3):373-81. PubMed ID: 9125676
    [Abstract] [Full Text] [Related]

  • 11. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.
    Kühlkamp V, Mewis C, Mermi J, Bosch RF, Seipel L.
    J Am Coll Cardiol; 1999 Jan 01; 33(1):46-52. PubMed ID: 9935007
    [Abstract] [Full Text] [Related]

  • 12. Infarct related artery patency: relation to serial electropharmacological studies and outcome in patients with previous myocardial infarction and ventricular tachyarrhythmias.
    Hoppe UC, Haverkamp W, Breithardt G, Borggrefe M.
    Pacing Clin Electrophysiol; 2000 May 01; 23(5):854-62. PubMed ID: 10833706
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of sotalol for drug-refractory malignant ventricular arrhythmias.
    Gonzalez R, Scheinman MM, Herre JM, Griffin JC, Sauve MJ, Sharkey H.
    J Am Coll Cardiol; 1988 Dec 01; 12(6):1568-72. PubMed ID: 3192854
    [Abstract] [Full Text] [Related]

  • 14. Long-term reproducibility of electrophysiologically guided therapy with sotalol in patients with ventricular tachyarrhythmias.
    Mewis C, Kühlkamp V, Mermi J, Bosch RF, Seipel L.
    J Am Coll Cardiol; 1999 Jun 01; 33(7):1989-95. PubMed ID: 10362204
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative efficacy of sotalol and class I antiarrhythmic agents in patients with ventricular tachycardia or fibrillation: results of the Electrophysiology Study Versus Electrocardiographic Monitoring (ESVEM) Trial.
    Klein RC.
    Eur Heart J; 1993 Nov 01; 14 Suppl H():78-84. PubMed ID: 8293756
    [Abstract] [Full Text] [Related]

  • 17. Electrophysiologic testing in assessment of therapy with sotalol for sustained ventricular tachycardia.
    Senges J, Lengfelder W, Jauernig R, Czygan E, Brachmann J, Rizos I, Cobbe S, Kübler W.
    Circulation; 1984 Mar 01; 69(3):577-84. PubMed ID: 6692518
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Determinants of the outcome of electrophysiologic study in patients with ventricular tachyarrhythmias.
    Schoenfeld MH, McGovern B, Garan H, Kelly E, Grant G, Ruskin JN.
    J Am Coll Cardiol; 1985 Aug 01; 6(2):298-306. PubMed ID: 4019918
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease.
    Kus T, Campa MA, Nadeau R, Dubuc M, Kaltenbrunner W, Shenasa M.
    Am Heart J; 1992 Jan 01; 123(1):82-9. PubMed ID: 1729853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.